<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Brum WS</submitter><funding>European Research Council</funding><pagination>36</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12479634</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>150(1)</volume><pubmed_abstract>Tau hyperphosphorylation, a key neuropathological feature of tauopathies such as Alzheimer's disease (AD), also occurs physiologically during mammalian hibernation and is fully reversed upon arousal, offering a unique translational model to study tau metabolism. However, limited data exist on insoluble and soluble tau alterations during hibernation and on patterns of tau fragment concentrations in the hibernating mammalian brain. We quantified tau biomarkers in plasma samples from ten free-ranging brown bears (Ursus arctos), captured during both their active summer period and hibernation in the winter, using clinically validated immunoassays and immunoprecipitation mass spectrometry (IP-MS) techniques. We also analyzed brain tissue from ten golden Syrian hamsters (Mesocricetus auratus) sub</pubmed_abstract><journal>Acta neuropathologica</journal><pubmed_title>Reversible tau hyperphosphorylation in hibernation: a blood biomarker and brain tissue study.</pubmed_title><pmcid>PMC12479634</pmcid><funding_grant_id>101096455</funding_grant_id><pubmed_authors>Lashley T</pubmed_authors><pubmed_authors>Ferrari-Souza JP</pubmed_authors><pubmed_authors>Zimmer ER</pubmed_authors><pubmed_authors>Zetterberg H</pubmed_authors><pubmed_authors>Piotrowska D</pubmed_authors><pubmed_authors>Kindberg J</pubmed_authors><pubmed_authors>Holzer M</pubmed_authors><pubmed_authors>Benedet AL</pubmed_authors><pubmed_authors>Martin S</pubmed_authors><pubmed_authors>Stieler JT</pubmed_authors><pubmed_authors>Isaksson HS</pubmed_authors><pubmed_authors>Janelidze S</pubmed_authors><pubmed_authors>Hansson O</pubmed_authors><pubmed_authors>Camporesi E</pubmed_authors><pubmed_authors>Jager C</pubmed_authors><pubmed_authors>Montoliu-Gaya L</pubmed_authors><pubmed_authors>Ashton NJ</pubmed_authors><pubmed_authors>Brum WS</pubmed_authors><pubmed_authors>Brinkmalm G</pubmed_authors><pubmed_authors>Arendt T</pubmed_authors><pubmed_authors>Frobert O</pubmed_authors><pubmed_authors>Lantero-Rodriguez J</pubmed_authors><pubmed_authors>Moscoso A</pubmed_authors><pubmed_authors>Blennow K</pubmed_authors><pubmed_authors>Gobom J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Reversible tau hyperphosphorylation in hibernation: a blood biomarker and brain tissue study.</name><description>Tau hyperphosphorylation, a key neuropathological feature of tauopathies such as Alzheimer's disease (AD), also occurs physiologically during mammalian hibernation and is fully reversed upon arousal, offering a unique translational model to study tau metabolism. However, limited data exist on insoluble and soluble tau alterations during hibernation and on patterns of tau fragment concentrations in the hibernating mammalian brain. We quantified tau biomarkers in plasma samples from ten free-ranging brown bears (Ursus arctos), captured during both their active summer period and hibernation in the winter, using clinically validated immunoassays and immunoprecipitation mass spectrometry (IP-MS) techniques. We also analyzed brain tissue from ten golden Syrian hamsters (Mesocricetus auratus) sub</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-06-03T23:32:44.712Z</modification><creation>2026-05-03T03:12:00.359Z</creation></dates><accession>S-EPMC12479634</accession><cross_references><pubmed>41023457</pubmed><doi>10.1007/s00401-025-02930-2</doi></cross_references></HashMap>